Report Detail

Pharma & Healthcare Global Oncology Generic Injectable Drugs Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

  • RnM3657758
  • |
  • 09 August, 2019
  • |
  • Global
  • |
  • 119 Pages
  • |
  • GIR (Global Info Research)
  • |
  • Pharma & Healthcare

Generic drugs are essential in oncology because some anticancer drugs are only available as generics.

Scope of the Report:
The worldwide market for Oncology Generic Injectable Drugs is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Oncology Generic Injectable Drugs in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers
Teva Pharmaceutical
Pfizer
AstraZeneca
Roche
Eli Lilly
GlaxoSmithKline
Novartis
Mylan
Natco Pharma

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Large Molecule Drugs
Small Molecule Drugs

Market Segment by Applications, can be divided into
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Oncology Generic Injectable Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Oncology Generic Injectable Drugs, with price, sales, revenue and global market share of Oncology Generic Injectable Drugs in 2017 and 2018.
Chapter 3, the Oncology Generic Injectable Drugs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Oncology Generic Injectable Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Oncology Generic Injectable Drugs market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Oncology Generic Injectable Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.


Table of Contents

    1 Market Overview

    • 1.1 Oncology Generic Injectable Drugs Introduction
    • 1.2 Market Analysis by Type
      • 1.2.1 Large Molecule Drugs
      • 1.2.2 Small Molecule Drugs
    • 1.3 Market Analysis by Applications
      • 1.3.1 Hospital Pharmacies
      • 1.3.2 Retail Pharmacies
      • 1.3.3 Online Pharmacies
    • 1.4 Market Analysis by Regions
      • 1.4.1 North America (United States, Canada and Mexico)
        • 1.4.1.1 United States Market States and Outlook (2014-2024)
        • 1.4.1.2 Canada Market States and Outlook (2014-2024)
        • 1.4.1.3 Mexico Market States and Outlook (2014-2024)
      • 1.4.2 Europe (Germany, France, UK, Russia and Italy)
        • 1.4.2.1 Germany Market States and Outlook (2014-2024)
        • 1.4.2.2 France Market States and Outlook (2014-2024)
        • 1.4.2.3 UK Market States and Outlook (2014-2024)
        • 1.4.2.4 Russia Market States and Outlook (2014-2024)
        • 1.4.2.5 Italy Market States and Outlook (2014-2024)
      • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
        • 1.4.3.1 China Market States and Outlook (2014-2024)
        • 1.4.3.2 Japan Market States and Outlook (2014-2024)
        • 1.4.3.3 Korea Market States and Outlook (2014-2024)
        • 1.4.3.4 India Market States and Outlook (2014-2024)
        • 1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
      • 1.4.4 South America, Middle East and Africa
        • 1.4.4.1 Brazil Market States and Outlook (2014-2024)
        • 1.4.4.2 Egypt Market States and Outlook (2014-2024)
        • 1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
        • 1.4.4.4 South Africa Market States and Outlook (2014-2024)
        • 1.4.4.5 Turkey Market States and Outlook (2014-2024)
    • 1.5 Market Dynamics
      • 1.5.1 Market Opportunities
      • 1.5.2 Market Risk
      • 1.5.3 Market Driving Force

    2 Manufacturers Profiles

    • 2.1 Teva Pharmaceutical
      • 2.1.1 Business Overview
      • 2.1.2 Oncology Generic Injectable Drugs Type and Applications
        • 2.1.2.1 Product A
        • 2.1.2.2 Product B
      • 2.1.3 Teva Pharmaceutical Oncology Generic Injectable Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.2 Pfizer
      • 2.2.1 Business Overview
      • 2.2.2 Oncology Generic Injectable Drugs Type and Applications
        • 2.2.2.1 Product A
        • 2.2.2.2 Product B
      • 2.2.3 Pfizer Oncology Generic Injectable Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.3 AstraZeneca
      • 2.3.1 Business Overview
      • 2.3.2 Oncology Generic Injectable Drugs Type and Applications
        • 2.3.2.1 Product A
        • 2.3.2.2 Product B
      • 2.3.3 AstraZeneca Oncology Generic Injectable Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.4 Roche
      • 2.4.1 Business Overview
      • 2.4.2 Oncology Generic Injectable Drugs Type and Applications
        • 2.4.2.1 Product A
        • 2.4.2.2 Product B
      • 2.4.3 Roche Oncology Generic Injectable Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.5 Eli Lilly
      • 2.5.1 Business Overview
      • 2.5.2 Oncology Generic Injectable Drugs Type and Applications
        • 2.5.2.1 Product A
        • 2.5.2.2 Product B
      • 2.5.3 Eli Lilly Oncology Generic Injectable Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.6 GlaxoSmithKline
      • 2.6.1 Business Overview
      • 2.6.2 Oncology Generic Injectable Drugs Type and Applications
        • 2.6.2.1 Product A
        • 2.6.2.2 Product B
      • 2.6.3 GlaxoSmithKline Oncology Generic Injectable Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.7 Novartis
      • 2.7.1 Business Overview
      • 2.7.2 Oncology Generic Injectable Drugs Type and Applications
        • 2.7.2.1 Product A
        • 2.7.2.2 Product B
      • 2.7.3 Novartis Oncology Generic Injectable Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.8 Mylan
      • 2.8.1 Business Overview
      • 2.8.2 Oncology Generic Injectable Drugs Type and Applications
        • 2.8.2.1 Product A
        • 2.8.2.2 Product B
      • 2.8.3 Mylan Oncology Generic Injectable Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.9 Natco Pharma
      • 2.9.1 Business Overview
      • 2.9.2 Oncology Generic Injectable Drugs Type and Applications
        • 2.9.2.1 Product A
        • 2.9.2.2 Product B
      • 2.9.3 Natco Pharma Oncology Generic Injectable Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

    3 Global Oncology Generic Injectable Drugs Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)

    • 3.1 Global Oncology Generic Injectable Drugs Sales and Market Share by Manufacturer (2017-2018)
    • 3.2 Global Oncology Generic Injectable Drugs Revenue and Market Share by Manufacturer (2017-2018)
    • 3.3 Market Concentration Rate
      • 3.3.1 Top 3 Oncology Generic Injectable Drugs Manufacturer Market Share in 2018
      • 3.3.2 Top 6 Oncology Generic Injectable Drugs Manufacturer Market Share in 2018
    • 3.4 Market Competition Trend

    4 Global Oncology Generic Injectable Drugs Market Analysis by Regions

    • 4.1 Global Oncology Generic Injectable Drugs Sales, Revenue and Market Share by Regions
      • 4.1.1 Global Oncology Generic Injectable Drugs Sales and Market Share by Regions (2014-2019)
      • 4.1.2 Global Oncology Generic Injectable Drugs Revenue and Market Share by Regions (2014-2019)
    • 4.2 North America Oncology Generic Injectable Drugs Sales and Growth Rate (2014-2019)
    • 4.3 Europe Oncology Generic Injectable Drugs Sales and Growth Rate (2014-2019)
    • 4.4 Asia-Pacific Oncology Generic Injectable Drugs Sales and Growth Rate (2014-2019)
    • 4.5 South America Oncology Generic Injectable Drugs Sales and Growth Rate (2014-2019)
    • 4.6 Middle East and Africa Oncology Generic Injectable Drugs Sales and Growth Rate (2014-2019)

    5 North America Oncology Generic Injectable Drugs by Country

    • 5.1 North America Oncology Generic Injectable Drugs Sales, Revenue and Market Share by Country
      • 5.1.1 North America Oncology Generic Injectable Drugs Sales and Market Share by Country (2014-2019)
      • 5.1.2 North America Oncology Generic Injectable Drugs Revenue and Market Share by Country (2014-2019)
    • 5.2 United States Oncology Generic Injectable Drugs Sales and Growth Rate (2014-2019)
    • 5.3 Canada Oncology Generic Injectable Drugs Sales and Growth Rate (2014-2019)
    • 5.4 Mexico Oncology Generic Injectable Drugs Sales and Growth Rate (2014-2019)

    6 Europe Oncology Generic Injectable Drugs by Country

    • 6.1 Europe Oncology Generic Injectable Drugs Sales, Revenue and Market Share by Country
      • 6.1.1 Europe Oncology Generic Injectable Drugs Sales and Market Share by Country (2014-2019)
      • 6.1.2 Europe Oncology Generic Injectable Drugs Revenue and Market Share by Country (2014-2019)
    • 6.2 Germany Oncology Generic Injectable Drugs Sales and Growth Rate (2014-2019)
    • 6.3 UK Oncology Generic Injectable Drugs Sales and Growth Rate (2014-2019)
    • 6.4 France Oncology Generic Injectable Drugs Sales and Growth Rate (2014-2019)
    • 6.5 Russia Oncology Generic Injectable Drugs Sales and Growth Rate (2014-2019)
    • 6.6 Italy Oncology Generic Injectable Drugs Sales and Growth Rate (2014-2019)

    7 Asia-Pacific Oncology Generic Injectable Drugs by Country

    • 7.1 Asia-Pacific Oncology Generic Injectable Drugs Sales, Revenue and Market Share by Country
      • 7.1.1 Asia-Pacific Oncology Generic Injectable Drugs Sales and Market Share by Country (2014-2019)
      • 7.1.2 Asia-Pacific Oncology Generic Injectable Drugs Revenue and Market Share by Country (2014-2019)
    • 7.2 China Oncology Generic Injectable Drugs Sales and Growth Rate (2014-2019)
    • 7.3 Japan Oncology Generic Injectable Drugs Sales and Growth Rate (2014-2019)
    • 7.4 Korea Oncology Generic Injectable Drugs Sales and Growth Rate (2014-2019)
    • 7.5 India Oncology Generic Injectable Drugs Sales and Growth Rate (2014-2019)
    • 7.6 Southeast Asia Oncology Generic Injectable Drugs Sales and Growth Rate (2014-2019)

    8 South America Oncology Generic Injectable Drugs by Country

    • 8.1 South America Oncology Generic Injectable Drugs Sales, Revenue and Market Share by Country
      • 8.1.1 South America Oncology Generic Injectable Drugs Sales and Market Share by Country (2014-2019)
      • 8.1.2 South America Oncology Generic Injectable Drugs Revenue and Market Share by Country (2014-2019)
    • 8.2 Brazil Oncology Generic Injectable Drugs Sales and Growth Rate (2014-2019)
    • 8.3 Argentina Oncology Generic Injectable Drugs Sales and Growth Rate (2014-2019)
    • 8.4 Colombia Oncology Generic Injectable Drugs Sales and Growth Rate (2014-2019)

    9 Middle East and Africa Oncology Generic Injectable Drugs by Countries

    • 9.1 Middle East and Africa Oncology Generic Injectable Drugs Sales, Revenue and Market Share by Country
      • 9.1.1 Middle East and Africa Oncology Generic Injectable Drugs Sales and Market Share by Country (2014-2019)
      • 9.1.2 Middle East and Africa Oncology Generic Injectable Drugs Revenue and Market Share by Country (2014-2019)
    • 9.2 Saudi Arabia Oncology Generic Injectable Drugs Sales and Growth Rate (2014-2019)
    • 9.3 Turkey Oncology Generic Injectable Drugs Sales and Growth Rate (2014-2019)
    • 9.4 Egypt Oncology Generic Injectable Drugs Sales and Growth Rate (2014-2019)
    • 9.5 Nigeria Oncology Generic Injectable Drugs Sales and Growth Rate (2014-2019)
    • 9.6 South Africa Oncology Generic Injectable Drugs Sales and Growth Rate (2014-2019)

    10 Global Oncology Generic Injectable Drugs Market Segment by Type

    • 10.1 Global Oncology Generic Injectable Drugs Sales, Revenue and Market Share by Type (2014-2019)
      • 10.1.1 Global Oncology Generic Injectable Drugs Sales and Market Share by Type (2014-2019)
      • 10.1.2 Global Oncology Generic Injectable Drugs Revenue and Market Share by Type (2014-2019)
    • 10.2 Large Molecule Drugs Sales Growth and Price
      • 10.2.1 Global Large Molecule Drugs Sales Growth (2014-2019)
      • 10.2.2 Global Large Molecule Drugs Price (2014-2019)
    • 10.3 Small Molecule Drugs Sales Growth and Price
      • 10.3.1 Global Small Molecule Drugs Sales Growth (2014-2019)
      • 10.3.2 Global Small Molecule Drugs Price (2014-2019)

    11 Global Oncology Generic Injectable Drugs Market Segment by Application

    • 11.1 Global Oncology Generic Injectable Drugs Sales Market Share by Application (2014-2019)
    • 11.2 Hospital Pharmacies Sales Growth (2014-2019)
    • 11.3 Retail Pharmacies Sales Growth (2014-2019)
    • 11.4 Online Pharmacies Sales Growth (2014-2019)

    12 Oncology Generic Injectable Drugs Market Forecast (2019-2024)

    • 12.1 Global Oncology Generic Injectable Drugs Sales, Revenue and Growth Rate (2019-2024)
    • 12.2 Oncology Generic Injectable Drugs Market Forecast by Regions (2019-2024)
      • 12.2.1 North America Oncology Generic Injectable Drugs Market Forecast (2019-2024)
      • 12.2.2 Europe Oncology Generic Injectable Drugs Market Forecast (2019-2024)
      • 12.2.3 Asia-Pacific Oncology Generic Injectable Drugs Market Forecast (2019-2024)
      • 12.2.4 South America Oncology Generic Injectable Drugs Market Forecast (2019-2024)
      • 12.2.5 Middle East and Africa Oncology Generic Injectable Drugs Market Forecast (2019-2024)
    • 12.3 Oncology Generic Injectable Drugs Market Forecast by Type (2019-2024)
      • 12.3.1 Global Oncology Generic Injectable Drugs Sales Forecast by Type (2019-2024)
      • 12.3.2 Global Oncology Generic Injectable Drugs Market Share Forecast by Type (2019-2024)
    • 12.4 Oncology Generic Injectable Drugs Market Forecast by Application (2019-2024)
      • 12.4.1 Global Oncology Generic Injectable Drugs Sales Forecast by Application (2019-2024)
      • 12.4.2 Global Oncology Generic Injectable Drugs Market Share Forecast by Application (2019-2024)

    13 Sales Channel, Distributors, Traders and Dealers

    • 13.1 Sales Channel
      • 13.1.1 Direct Marketing
      • 13.1.2 Indirect Marketing
      • 13.1.3 Marketing Channel Future Trend
    • 13.2 Distributors, Traders and Dealers

    14 Research Findings and Conclusion

      15 Appendix

      • 15.1 Methodology

      Summary:
      Get latest Market Research Reports on Oncology Generic Injectable Drugs . Industry analysis & Market Report on Oncology Generic Injectable Drugs is a syndicated market report, published as Global Oncology Generic Injectable Drugs Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024. It is complete Research Study and Industry Analysis of Oncology Generic Injectable Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,480.00
      $5,220.00
      $6,960.00
      2,756.16
      4,134.24
      5,512.32
      3,222.48
      4,833.72
      6,444.96
      526,698.00
      790,047.00
      1,053,396.00
      290,232.00
      435,348.00
      580,464.00
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report